# UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma

> **NCT00045500** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** 7-hydroxystaurosporine
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00045500
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045500, "UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00045500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*